Derivation of human peripheral blood derived endothelial progenitor cells and the role of osteopontin surface modification and eNOS transfection

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7292-7301

  Yuan, Yifan ^a,b   Altalhi, Wafa A ^a,b   Ng, Jeannette J ^a,b   Courtman, David W ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cell adhesion; Endothelium; Gene expression; Osteopontin; Progenitor cell

Indexed keywords

ENDOTHELIAL NITRIC-OXIDE SYNTHASE (ENOS); ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIAL PROGENITOR CELLS (EPCS); ENDOTHELIUM; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; OSTEOPONTIN; PROGENITOR CELL; TIME-DEPENDENT RESPONSE;

BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; CELL ADHESION; COATINGS; ENDOTHELIAL CELLS; GENE EXPRESSION; NITRIC OXIDE; REPAIR;

MOLECULAR BIOLOGY;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; OSTEOPONTIN;

ARTICLE; BLOOD; BLOOD VESSEL INJURY; CELL ADHESION; CELL MIGRATION; DOSE RESPONSE; ELECTROPORATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL ADHESION; ENDOTHELIUM; GENE EXPRESSION; OSTEOPONTIN; PROGENITOR CELL;

ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL SHAPE; DNA; ELECTRIC IMPEDANCE; ELECTRICITY; ELECTROPORATION; ENDOTHELIAL CELLS; HUMANS; IMMOBILIZED PROTEINS; MICROARRAY ANALYSIS; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE III; OSTEOPONTIN; RNA; STEM CELLS; SURFACE PROPERTIES; TRANSFECTION;

EID: 84880513736     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.003     Document Type: Article

References (50)

1. Khan O.F., Sefton M.V. Endothelialized biomaterials for tissue engineering applications invivo. Trends Biotechnol 2011, 29:379-387.
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972.
4. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000, 86:1198-1202.
5. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of exvivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427.
6. Masuda H., Kalka C., Asahara T. Endothelial progenitor cells for regeneration. Hum Cell 2000, 13:153-160.
7. Mauricio R., de Sousa G., Seghatchian J. What's happening: an overview of potential adverse reactions associated with apheresis technology. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis 2005, 33:351-356.
8. Moog R. Apheresis techniques for collection of peripheral blood progenitor cells. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis 2004, 31:207-220.
9. Taljaard M., Ward M.R., Kutryk M.J., Courtman D.W., Camack N.J., Goodman S.G., et al. Rationale and design of enhanced angiogenic cell therapy in acute myocardial infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. Am Heart J 2010, 159:354-360.
10. Ormiston M.L., Deng Y., Stewart D.J., Courtman D.W. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am J Respir Cell Mol Biol 2010, 43:546-554.
11. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
12. Stroncek J.D., Ren L.C., Klitzman B., Reichert W.M. Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model. Acta Biomater 2012, 8:201-208.
13. Avci-Adali M., Ziemer G., Wendel H.P. Induction of EPC homing on biofunctionalized vascular grafts for rapid invivo self-endothelialization-a review of current strategies. Biotechnol Adv 2010, 28:119-129.
14. Leen L.L., Filipe C., Billon A., Garmy-Susini B., Jalvy S., Robbesyn F., et al. Estrogen-stimulated endothelial repair requires osteopontin. Arterioscler Thromb Vasc Biol 2008, 28:2131-2136.
15. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol J Int Soc Matrix Biol 2000, 19:615-622.
16. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., Berman J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. JClin Invest 2001, 107:1055-1061.
17. Molin D.G., van den Akker N.M., Post M.J. Affirmative action of osteopontin on endothelial progenitors. Arterioscler Thromb Vasc Biol 2008, 28:2099-2100.
18. Liaw L., Almeida M., Hart C.E., Schwartz S.M., Giachelli C.M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells invitro. Circ Res 1994, 74:214-224.
19. Otsuka F., Finn A.V., Yazdani S.K., Nakano M., Kolodgie F.D., Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 2012, 9:439-453.
20. Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992, 145:201-227.
21. Murohara T., Witzenbichler B., Spyridopoulos I., Asahara T., Ding B., Sullivan A., et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999, 19:1156-1161.
22. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003, 93:1023-1025.
23. Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Ilasaca M., Perrella M.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
24. Cui B., Huang L., Fang Y., Guo R., Yin Y., Zhao X. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Microvasc Res 2011, 81:143-150.
25. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
26. Planat-Benard V., Silvestre J.S., Cousin B., Andre M., Nibbelink M., Tamarat R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109:656-663.
27. Dreger P., Kloss M., Petersen B., Haferlach T., Loffler H., Loeffler M., et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995, 86:3970-3978.
28. Lasky L.C., Hurd D.D., Smith J.A., Haake R. Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantation. Transfusion 1989, 29:323-327.
29. Hernandez D.A., Townsend L.E., Uzieblo M.R., Haan M.E., Callahan R.E., Bendick P.J., et al. Human endothelial cell cultures from progenitor cells obtained by leukapheresis. Am Surg 2000, 66:355-358. discussion 9.
30. Korbling M., Reuben J.M., Gao H., Lee B.N., Harris D.M., Cogdell D., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 2006, 46:1795-1802.
31. Rohde E., Malischnik C., Thaler D., Maierhofer T., Linkesch W., Lanzer G., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24:357-367.
32. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
33. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. JClin Invest 2000, 105:71-77.
34. Prater D.N., Case J., Ingram D.A., Yoder M.C. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007, 21:1141-1149.
35. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
36. Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., et al. Invitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000, 95:3106-3112.
37. Hill J.M., Syed M.A., Arai A.E., Powell T.M., Paul J.D., Zalos G., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. JAm Coll Cardiol 2005, 46:1643-1648.
38. Tura O., Crawford J., Barclay G.R., Samuel K., Hadoke P.W., Roddie H., et al. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis invivo and invitro: implications for sourcing cells for vascular regeneration therapy. JThromb Haemost 2010, 8:1614-1623.
39. Boyer M., Townsend L.E., Vogel L.M., Falk J., Reitz-Vick D., Trevor K.T., et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. JVasc Surg 2000, 31:181-189.
40. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996, 271:509-512.
41. Leali D., Moroni E., Bussolino F., Presta M. Osteopontin overexpression inhibits invitro re-endothelialization via integrin engagement. JBiol Chem 2007, 282:19676-19684.
42. Senger D.R., Perruzzi C.A. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim Biophys Acta 1996, 1314:13-24.
43. Yu M., Liu Q., Yi K., Wu L., Tan X. Effects of osteopontin on functional activity of late endothelial progenitor cells. JCell Biochem 2011, 112:1730-1736.
44. Denhardt D.T., Giachelli C.M., Rittling S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001, 41:723-749.
45. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007, 27:2302-2309.
46. Yokosaki Y., Matsuura N., Sasaki T., Murakami I., Schneider H., Higashiyama S., et al. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. JBiol Chem 1999, 274:36328-36334.
47. Hall A. Signal transduction pathways regulated by the Rho family of small GTPases. Br J Cancer 1999, 80(Suppl.1):25-27.
48. Bourguignon L.Y. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. JMammary Gland Biol Neoplasia 2001, 6:287-297.
49. Tiwari A., Jung J.J., Inamdar S.M., Brown C.O., Goel A., Choudhury A. Endothelial cell migration on fibronectin is regulated by syntaxin 6-mediated alpha5beta1 integrin recycling. JBiol Chem 2011, 286:36749-36761.
50. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003, 284:H1577-H1584.